Human netrin-1
CA 2250263 C · Owner: The Regents Of The University Of California · Inventors: Zhang, Yuan; Serafini, Tito; Tessier-Lavigne, Marc
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Specific netrin proteins, nucleic acids which encode netrin proteins and hybridization reagents, probes and primers capable of hybridizing with netrin genes and methods for screening chemical libraries for lead compounds for pharmacological agents useful in the diagnosis or treatment of disease associated undesirable cell growth are provided. An exemplary screen involves forming a mixture comprising a recombinant netrin protein a natural , intracellular netrin protein binding target and a candidate pharmacological agent; incubating the mixture under conditions whereby but for the presence , of said candidate pharmacological agent said netrin protein selectively binds said binding …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 19, 1997 and granted August 20, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 19, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 19, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.